Skip to main content

An association study between various monoamine transporter gene polymorphisms and treatment response to mirtazapine in major depression

Background

Genetic differences may contribute to the inter-individual differences in treatment response to antidepressants among patients suffering from major depression. This study investigated a possible association of various monoamine transporter genetic polymorphisms with treatment response to mirtazapine in major depressive patients in elderly.

Materials and methods

In this study, three genetic polymorphisms were selected: serotonin transporter 5-HTTLPR, serotonin transporter 5-HTT intron 2 VNTR, and norepinephrine transporter NET(G1287A). The patients with major depression diagnosed by DSM-IV were recruited to a 6-week naturalistic mirtazapine treatment study in Samsung Medical Center. Treatment response to mirtazapine was defined as ≥50% decrease in HAMD-17 scores at 6 weeks, and the genotypes in the patients were determined using the polymerase chain reaction.

Results

Our results showed that ss allele carriers were included more in responder group(ss allele in responder vs. non responder group; 69.4% vs. 40.0%). In addition, l-allele (sl/ll) carriers were included less in responder group(sl/ll allele in responder vs. non responder group; 30.6% vs. 60.0%). Multiple logistic regression analyses showed the 5-HTTLPR polymorphism as an predictor of the mirtazapine response (5HTTLPR ss allele carrier vs. l-allele (sl/ll) carrier; odds ratio: 3.81; 95% confidence interval [CI], 1.32-11.0; P = 0.013). However, 5-HTT intron 2 VNTR l/s (P = 0.33 by multiple logistic regression; [OR], 0.53; 95% [CI], 0.15-1.88), and NET(G1287A) G/A (P = 0.68 by multiple logistic regression; [OR], 1.25; 95% [CI], 0.44-3.53) showed no statistical significant influences on response rate.

Conclusions

In conclusion, 5HTTLPR polymorphism may predict treatment response to mirtazapine in major depressive patients in elderly.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hong Choi.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Choi, H. An association study between various monoamine transporter gene polymorphisms and treatment response to mirtazapine in major depression. Ann Gen Psychiatry 9, S203 (2010). https://doi.org/10.1186/1744-859X-9-S1-S203

Download citation

Keywords

  • Treatment Response
  • Major Depression
  • Genetic Polymorphism
  • Mirtazapine
  • Multiple Logistic Regression Analysis